Rzerra (ofatumumab) - Recommendations To Screen, Monitor And To Manage Hepatitis B Virus Reactivation - For Health Professionals
RZERRA Recall Summary RZERRA (ofatumumab) is a drug used to treat certain conditions, and health professionals are being notified to screen, monitor, and manage the risk of Hepatitis B virus reactivation in patients taking this medication. This notification applies to all patients in Canada who are currently using or may use RZERRA. The update is being issued due to product safety concerns related to potential Hepatitis B reactivation.
- Reason
- Product safety
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2014-01-27
- Status
- Closed
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/0509d62d-83aa-4665-a9f6-0058e266bfc3